IMAI Alliance
Follow IMAI on Twitter Like IMAI on Facebook Join Us on LinkedIn
Home About Us Countries Clinical Team Resources Contact Us Donate Now
About Us
Clinical Team Resources
  WHO informal consultation on fever management
  Sierra Leone Ebola Treatment Center Guide Dec2014
  WHO Ebola clinical training course
  WHO Viral Haemorrhagic Fever pocketbook
Read More
Happening Now
NPR Article: What should you do if a fly gets into your anti-ebola goggles?
NPR Article: Test Your Medical Smarts: Does this patient have Ebola?
Intercountry Ebola Clinical Training of Trainers
Breast augmentation is a surgical operation aimed at change of the form and size of a woman’s breasts using silicone implants. Here you can learn how to lift sagging breast and more. On Rhinoplasty blog you can learn more about rhinoplasty surgery! Do plastic surgery now!
WHO Ebola Clinical Team Training for Ebola Treatment Unit Work
Read More
Board of Directors  •  Alliance HQ Team
Board of Directors
Sandy Gove MD, MPH - Chair

After training in internal medicine and clinical epidemiology at UCSF and UC Berkeley, Sandy spent 3 year in Somalia working on maternal and child health and tuberculosis control. She joined the World Health Organization (WHO) Control of Diarrhoeal Diseases program in 1990 to develop the first Acute Respiratory Infection/childhood pneumonia program, then was the technical lead for its expansion to Integrated Management of Childhood Illness (IMCI), a strategy adapted for use in more than 100 countries. From 1996 to 2000 she worked on the development of the Integrated Management of Pregnancy and Childbirth (through the WHO reproductive health department) and the Practical Approach to Lung Health, which incorporated the management of adult pneumonia, asthma and COPD with that for TB (through the WHO TB department). From 2000 to her retirement from WHO in 2011, she led the development and implementation of Integrated Management of Adolescent and Adult Illness (IMAI). Through her work with IMAI, Dr. Gove coordinated the IMAI first-level (health centre) programme which included the development of the guideline manuals, Acute Care, Chronic HIV Care/ART, Palliative care amongst others, with their associated clinical training programme through their adaptation, field-testing and implementation in countries. The first level tools were used extensively in Africa to support the scale up of antiretroviral therapy and HIV care through an integrated approach. This training programme is participatory and established the use of expert-patient trainers, people living with HIV/AIDS, to simulate clinical cases in order to train health workers from various cadres (doctors, nurses, and auxiliary staff) in resource-limited settings.

Dr. Gove also was instrumental in leading the evidence-baseddevelopment of theWHO IMAI District Clinician Manual (DCM), published in 2012, through an extensive coordination of global experts and working groups across multiple disciplines. This manual provides management guidelines for clinicians working at district hospitals in limited resource settings. Dr. Gove then developed and implemented the IMAI 2nd level learning programme for district hospitals based on the DCM. Through a clinical team, participatory approach, health workers from all cadres (clinicians-doctors and nurses, managers, and auxiliary staff) are trained in triage, emergency care and treatment, critical care management, disease surveillance and case reporting, and infection prevention and control, including for viral haemorragic fever.

Within WHO, IMAI has been housed in the WHO Stop TB program, then the Department for Neglected Tropical Diseases, then the HIV Department. IMAI now receives substantial WHO support from the Pandemic and Epidemic Diseases Department, given its relevance to surveillance and case management of notifiable diseases. Sandy retired from WHO In 2011 and continues to work on providing technical support in theIMAI approach and its implementation in countries as Executive Director of the IMAI-IMCI Alliance. In Uganda, Dr. Gove, with the Alliance team, worked with the Ugandan Ministry of Health in the adaptation of the IMAI District Clinician Manual, which incorporates all relevant communicable and non-communicable diseases of adolescents and adults, including the development of the pocket guide for viral haemorrhagic fever for health workers. She continues to advocate for an integrated approach to the district management of adult illness in limited- resource countries- with an integrated approach to caring for each patient, as well as functional integration between the community, health centre and hospital levels of care- and the relevance of these integrated tools for multiple global health programs.

Gary Slutkin, MD
Dr. Gary Slutkin

Dr. Gary Slutkin is a physician and epidemiologist and the Founder and Executive Director of Cure Violence, a scientifically proven, public health approach to violence reduction which uses behavior change and epidemic control methods. Cure Violence has been statistically demonstrated to reduce shootings and killings by up to 41% to 73% by four extensive independently funded and independently performed studies – by the U.S. Department of Justice, Johns Hopkins University, the U.S. Centers for Disease Control, and others. U.S. Attorney General Eric Holder, Jr., referred to Cure Violence as "a rational, data-driven, evidence-based, smart approach (to reducing violence)" The World in 2009 edition of The Economist heralded CureViolence as "the approach that will come to prominence." In 2013, Cure Violence was named one of the 10 best non-governmental organizations (NGOs) in the world by the Global Journal – and listed first among organizations dedicated to reducing violence.

Dr. Slutkin is a Professor of Epidemiology and International Health at the University of Illinois at Chicago, a senior advisor to the World Health Organization (WHO), a global Ashoka fellow, and the 2009 Winner of the Search for Common Ground Award. He received his M.D. from the University of Chicago Pritzker School Of Medicine, and completed his internship, residency, and infectious disease training at UCSF/San Francisco General Hospital. Before working on reducing violence, Dr. Slutkin ran the Tuberculosis (TB) Program for San Francisco (1981- 5); moved to Somalia to work on TB and cholera epidemics (1985-7); and was then recruited by the World Health Organization where he worked from 1987 to 1994 in over 20 countries, including leading the efforts – using behavior change methods - to reverse the AIDS epidemic in Uganda. He was then appointed Director of Intervention Development for WHO (global).

Dr. Slutkin sees violence as a contagious process, which has now been confirmed by the most recent Institute of Medicine Report, The Contagion of Violence. Cure Violence has been designed to be complementary and synergistic with law enforcement efforts towards enhanced effects at community level.

The Cure Violence method is working in over 60 communities in 25 cities in the U.S. and in countries on three continents including programs in the UK, Jamaica, Trinidad, Honduras, Brazil, South Africa and Iraq. Cure Violence is funded by the U.S. Department of Justice, the Robert Wood Johnson Foundation, the World Bank, the Inter American Development Bank (IDB), and multiple national, international and local foundations and city, state and federal governments.

Dr. Slutkin's work has been featured in The Interrupters, a documentary film about the work of Cure Violence, most recently in NIcholas Kristof and Cheryl WuDunn's book, A Path Appears, and has won numerous national and international awards including the Attorney General's Award for Outstanding Contributions to Community Partnerships for Public Safety. Dr. Slutkin is currently working on a book regarding these new methods for understanding and reducing lethal violence.

Phil Hopewell, MD
Dr. Phil Hopewell

Dr. Philip C. Hopewell has been practicing medicine for 49 years. Dr. Hopewell graduated from the West Virginia University School of Medicine in 1965. He practices medicine in San Francisco, CA and specializes in Pediatric Critical Care Medicine. Dr. Hopewell is affiliated with UCSF Medical Center Mount Zion, San Francisco General Hospital Medical Center and UCSF Medical Center Parnassus. He speaks English, Chinese, Spanish and Vietnamese.

Shevin T. Jacob, MD, MPH

Board certified in infectious diseases, Dr. Jacob is an Acting Assistant Professor in Allergy and Infectious Diseases in the Department of Medicine and also the Associate Director of the International Respiratory and Severe Illness Center (INTERSECT) at the University of Washington (UW). Currently based in Uganda, Dr. Jacob is serving as the UW Principal Investigator for a multi-site randomized controlled trial to evaluate the efficacy of a management bundle for adult sepsis in resource-limited studies. The research in Uganda is part of a larger multi-national research consortium called the Austere environment Consortium for Enhanced Sepsis Outcomes (ACESO) for which Dr. Jacob is the Consortium Deputy Director and Uganda Country Director.

Since 2009, Dr. Jacob has served as a consultant to the World Health Organization as part of various working groups to improve the clinical management of sepsis and other severe illnesses in resource-limited settings. He was one of the technical editors for the WHO Integrated Management of Adolescent and Adult Illness (IMAI) District Clinician Manual and, through work with the IMAI Alliance (an implementing partner of the WHO), has helped to develop and implement the related training course focusing on triage, emergency management of severe illness and the clinician's role in disease surveillance, infection control and outbreak response. Most recently, he has also been actively involved as part of the WHO clinical response team to the ongoing ebola outbreak in Guinea, Sierra Leone and Liberia.

In addition, Dr. Jacob co-founded and serves on the Board of Directors of WALIMU- a nonprofit organization that aims to decrease the number of preventable deaths in resource-constrained hospitals within Uganda through a systematic, evidence-based quality improvement model. He is also the Chief Medical Officer for Shift Labs, a Seattle-based start-up company focused on developing low cost health technology solutions for low resource settings.

Hillary Cohen, MD

Dr. Cohen is an Emergency Medicine physician at the Maimonides Medical Center in Brooklyn, NY. Dr. Cohen facilitated in the development of the IMAI District Clinician Manual and was the lead physician involved in writing and field-testing the IMAI 2nd level clinical training course for district clinicians working at hospitals in limited resource settings. This training program provides evidence-based guidelines in triage, emergency care and treatment, and ongoing management of the severely ill patient with a specific focus on severe respiratory distress and septic shock. Dr. Cohen has served on the board of the Alliance since its inception. She also continues to contribute to the technical development and revisions of the the IMAI 2nd level learning programme as the Alliance lead on the IMAI Technical Assistance Project (TAP).

Mona Shah, MD, MPH - Treasurer, Secretary
Dr. Mona Shah

Dr. Shah is a board certified physician in General Preventive Medicine and Public Health and currently serves as the Treasurer and Secretary on the Board of Directors. She has worked with the WHO IMAI team since 2004, initially in the development, field-testing and scale up of the WHO IMAI 1st-level learning programme in Uganda. This clinical training was created in support of the WHO "3 by 5" initiative and geared towards integrating chronic HIV care and treatment at the health centre level. After completing her post graduate training at Johns Hopkins in 2007, Dr. Shah worked as a medical consultant with WHO IMAI and was involved with the development of the District Clinician Manual (DCM), its evidence basis, and the IMAI 2nd-level learning programme. Based on the DCM guidelines and through a clinical team approach, this programme trains health workers from all cadres (doctors, nurses, managers and auxiliary staff) working at the district hospital in limited resource settings.

In 2010, Dr. Shah helped establish the IMAI Alliance as a nonprofit organization in Florida in order to work with countries to facilitate in both technical support and implementation of the WHO IMAI approach. In addition to her work with the Alliance, Dr. Shah serves as the TB physician for Pinellas County at the Florida Department of Health in Pinellas County in the Division of Communicable Diseases.

For information regarding nominations and the board election process, please contact Katherine Bloomquist at

Back to Top
Alliance HQ Team
Dr. Sandy Gove - Executive Director
Dr. Mona Shah - Director of Operations
Dr. Hillary Cohen - Director - Technical Assistance Project
Katherine Bloomquist - Program Manager
Back to Top
Home | About Us | Programs | Organizational Documents | Clinical Team Resources | Contact Us | Admin
The IMAI Alliance is a registered 501(c)3 Non Profit. @imaialliance © 2014 IMAI IMCI Alliance.